Deepbridge Confirms Latest £1m SEIS Life Sciences Funding
- On March 24, 2021
- By GrowthInvest Marketing
Venture capital investment manager Deepbridge Capital has announced the completion of its latest Life Sciences SEIS £1m funding round.
Companies receiving seed-stage funding include Carocell Bio, Circada, FlutterLab, GenoMe Diagnostics, Glucose Republic and NanOptima.
The Deepbridge Life Sciences SEIS enables private investors to access a portfolio of early-stage companies within the UK’s vibrant life sciences sector, whilst benefiting from the generous potential tax reliefs available via the Government’s Seed Enterprise Investment Scheme (SEIS).
Deepbridge also manages the Deepbridge Life Sciences EIS, the Deepbridge Technology Growth EIS and the Deepbridge Innovation SEIS.
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest